June 26 (Reuters) - Medtronic said on Wednesday
its Chief Financial Officer Karen Parkhill will resign from the
company to accept a similar role at HP Inc.
Parkhill will continue to serve as CFO until Aug. 2, while
the company evaluates internal and external candidates to
replace her.
Gary Corona, senior vice president, global financial
planning and analysis, will serve as interim finance chief upon
Parkhill's departure.
(Reporting by Sneha S K in Bengaluru; Editing by Shailesh
Kuber)
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows:
- general and minimally invasive surgery (25%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.;
- cardiac rhythm management (19%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.;
- vascular diseases and cardiac surgery (18.1%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.;
- cranial and spinal technologies (14.8%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity;
- neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.7%);
- diabetes management (8.2%): internal and external glycemia monitoring systems and insulin pumps;
- neurological disorders (5.7%): neurostimulation and pumped medication administration products, diagnostic tools, etc. ;
- other (0.5%).
Net sales are distributed geographically as follows: Ireland (0.3%), the United States (51.2%) and other (48.5%).
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
